• bristol myers to acquire rayzebio for $62.50 per share in cash TipRanks Wed, 16 Apr 2025 03:24:02 GMT
• Neuroendocrine tumors Pipeline Analysis and Clinical Trials openPR.com Wed, 09 Apr 2025 07:00:00 GMT
• 2025 forecast: as companies rush to radiopharmaceuticals for oncology, what's next? Fierce Pharma Fri, 10 Jan 2025 08:00:00 GMT
• Radiopharmaceutical trials face extra complexities due to nuclear red tape Clinical Trials Arena Fri, 29 Nov 2024 08:00:00 GMT
• novartis drops up to $745m to move deeper into competitive radiopharma space BioSpace Mon, 18 Nov 2024 08:00:00 GMT
• bristol raises guidance on demand for eliquis, new drugs BNN Bloomberg Thu, 31 Oct 2024 07:00:00 GMT
• bristol-myers agrees deal to buy rayzebio for about $4.1 billion MSN Fri, 18 Oct 2024 07:45:52 GMT
• RayzeBio, Dice alums raise $370 million for new autoimmune startup statnews.com Mon, 09 Sep 2024 07:00:00 GMT
• With $370M debut, Candid Therapeutics is upfront about goal to lead a coming T-cell engager wave Fierce Biotech Mon, 09 Sep 2024 07:00:00 GMT
• Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease BioPharma Dive Mon, 09 Sep 2024 07:00:00 GMT
• Investors pour $370M+ into Ken Song’s autoimmune biotech after his RayzeBio success Endpoints News Mon, 09 Sep 2024 07:00:00 GMT
• trending tickers: latest investor updates on intel, tencent, rayzebio and astrazeneca Yahoo Finance UK Fri, 06 Sep 2024 13:52:53 GMT
• trending tickers: latest investor updates on intel, tencent, rayzebio and astrazeneca Yahoo Finance UK Thu, 05 Sep 2024 14:12:50 GMT
• trending tickers: latest investor updates on intel, tencent, rayzebio and astrazeneca Yahoo Finance UK Mon, 02 Sep 2024 21:34:08 GMT
• trending tickers: latest investor updates on intel, tencent, rayzebio and astrazeneca Yahoo Finance UK Fri, 30 Aug 2024 05:44:14 GMT
• trending tickers: latest investor updates on intel, tencent, rayzebio and astrazeneca Yahoo Finance UK Sat, 24 Aug 2024 04:46:13 GMT
• Former RayzeBio CEO quickly returns with new biotech; Amgen’s global research leader steps down Endpoints News Fri, 02 Aug 2024 07:00:00 GMT
• Updated: Bristol Myers restarts radiopharmaceutical Phase 3 trial Endpoints News Mon, 29 Jul 2024 07:00:00 GMT
• bms chief christopher boerner says company is still open to deals after spending more than $20b on m&a last year Fierce Pharma Wed, 12 Jun 2024 07:00:00 GMT
• BMS, RayzeBio halt radiotherapy trial due to isotope shortage TechTarget Wed, 05 Jun 2024 07:00:00 GMT
• RayzeBio warned of potential isotope supply issues before BMS deal Endpoints News Wed, 05 Jun 2024 07:00:00 GMT
• Bristol Myers' RayzeBio halts radiotherapy trial enrollment after isotope runs scarce Fierce Pharma Mon, 03 Jun 2024 07:00:00 GMT
• supply constraints force pause of bms, rayzebio cancer study FiercePharma Mon, 03 Jun 2024 07:00:00 GMT
• Exclusive: Isotope shortage forces pause of Bristol Myers Phase 3 radiopharmaceutical trial Endpoints News Sun, 02 Jun 2024 07:00:00 GMT
• bristol myers to buy rayzebio for more than 100% premium, in a deal valued at $4.1 billion MSN Sat, 18 May 2024 08:37:05 GMT
• bristol myers posts quarterly loss, lays out $1.5 billion cost-saving plan MSN Fri, 17 May 2024 12:39:31 GMT
• radiopharmaceutical cdmo/cmo services market to reach usd 5.44 billion by 2031 - exclusive report by insightace analytic PR Newswire UK Thu, 16 May 2024 07:00:00 GMT
• midday movers: intel's israel deal, bristol-myers squibb buys rayzebio MSN Tue, 14 May 2024 15:04:44 GMT
• bristol-myers squibb company (bmy) presents at guggenheim securities radiopharmaceuticals day (transcript) Seeking Alpha Mon, 13 May 2024 07:00:00 GMT
• bristol-myers agrees deal to buy rayzebio for about $4.1 billion MSN Wed, 08 May 2024 10:48:11 GMT
• bristol myers squibb agrees to acquire rpt company rayzebio for $4.1bn MSN Wed, 08 May 2024 01:46:58 GMT
• bristol myers squibb agrees to acquire rpt company rayzebio for $4.1bn MSN Tue, 07 May 2024 15:11:36 GMT
• bristol myers squibb to participate in upcoming investor conferences Business Wire Tue, 07 May 2024 07:00:00 GMT
• fusion pharmaceuticals an 'attractive' takeover target following recent radiopharma deals, oppenheimer says MSN Mon, 06 May 2024 22:57:27 GMT
• novartis pays peptidream $180m as radiopharma big bang continues Fierce Biotech Tue, 30 Apr 2024 07:00:00 GMT
• bms decision to lay off 2,200 employees comes after m&a spending spree BioSpace Fri, 26 Apr 2024 07:00:00 GMT
• bristol myers posts quarterly loss, lays out $1.5 bln cost-saving plan Reuters Thu, 25 Apr 2024 15:12:00 GMT
• 8138 shares in rayzebio, inc. (nasdaq:ryzb) bought by sg americas securities llc Defense World Sat, 06 Apr 2024 08:20:12 GMT
• rayzebio and genentech show interest in radiopharmaceuticals continues to grow Scrip Fri, 05 Apr 2024 02:53:41 GMT
• citigroup inc. invests $553000 in rayzebio, inc. (nasdaq:ryzb) Defense World Sat, 23 Mar 2024 08:35:48 GMT
• teachers retirement system of the state of kentucky buys new holdings in rayzebio, inc. (nasdaq:ryzb) Defense World Fri, 22 Mar 2024 08:41:48 GMT
• why fusion pharma is the latest billion dollar big pharma buy in radiopharmaceuticals Life Science Leader Magazine Fri, 22 Mar 2024 07:00:00 GMT
• lianbio (nasdaq:lian) and rayzebio (nasdaq:ryzb) critical analysis Defense World Thu, 21 Mar 2024 07:15:39 GMT
• wellington management group llp purchases new stake in rayzebio, inc. (nasdaq:ryzb) Defense World Tue, 19 Mar 2024 09:25:48 GMT
• provectus biopharmaceuticals (otcmkts:pvct) versus rayzebio (nasdaq:ryzb) head to head survey Defense World Sun, 10 Mar 2024 08:28:36 GMT
• financial comparison: rayzebio (nasdaq:ryzb) vs. provectus biopharmaceuticals (otcmkts:pvct) American Banking News Sun, 10 Mar 2024 08:26:49 GMT
• rayzebio, inc.'s lock-up period will expire on march 13th (nasdaq:ryzb) Defense World Wed, 06 Mar 2024 08:00:00 GMT
• bristol myers squibb acquires oncology firm rayzebio for $4.1 billion, marking a milestone in radiotherapeutics BNN Breaking Tue, 05 Mar 2024 12:33:00 GMT
• Q&A: Ken Song details RayzeBio’s path from Series A to IPO in 3 years, taking a down round and being disciplined Endpoints News Tue, 05 Mar 2024 08:00:00 GMT
• acuta capital partners llc makes new investment in rayzebio, inc. (nasdaq:ryzb) MarketBeat Mon, 04 Mar 2024 05:52:36 GMT
• acuta capital partners llc makes new investment in rayzebio, inc. (nasdaq:ryzb) MarketBeat Sun, 03 Mar 2024 17:02:19 GMT
• venbio partners llc makes new $114.51 million investment in rayzebio, inc. (nasdaq:ryzb) MarketBeat Sun, 03 Mar 2024 00:00:00 GMT
• venbio partners llc makes new $114.51 million investment in rayzebio, inc. (nasdaq:ryzb) MarketBeat Sat, 02 Mar 2024 15:23:12 GMT
• bristol myers squibb acquires majority stake in rayzebio for $4.1 billion DOTmed HealthCare Business News Fri, 01 Mar 2024 08:00:00 GMT
• bms bolsters oncology portfolio with $4.1bn rayzebio buy BioProcess Insider Thu, 29 Feb 2024 12:29:10 GMT
• bristol myers completes acquisition of rayzebio - tipranks.com TipRanks Tue, 27 Feb 2024 14:24:33 GMT
• Bristol Myers Squibb acquires RayzeBio for $4.1bn Pharmaceutical Technology Tue, 27 Feb 2024 08:00:00 GMT
• Bristol Myers Squibb Acquire RayzeBio for $4.1 Billion European Pharmaceutical Manufacturer Tue, 27 Feb 2024 08:00:00 GMT
• Big deals confirm renewed interest in radiopharmaceuticals | Business Chemistry World Tue, 27 Feb 2024 08:00:00 GMT
• bristol myers squibb concludes acquisition of rayzebio Medical Dialogues Tue, 27 Feb 2024 08:00:00 GMT
• bristol myers squibb completes acquisition of rayzebio, adding differentiated actinium-based radiopharmaceutical ... PharmiWeb.com Tue, 27 Feb 2024 08:00:00 GMT
• bristol myers squibb completes acquisition of rayzebio, adding differentiated actinium-based radiopharmaceutical platform Yahoo Finance Mon, 26 Feb 2024 08:00:00 GMT
• bristol myers squibb completes rayzebio acquisition by investing.com Investing.com Mon, 26 Feb 2024 08:00:00 GMT
• bristol myers completes acquisition of rayzebio - tipranks.com TipRanks Mon, 26 Feb 2024 08:00:00 GMT
• bms bolsters oncology portfolio with $4.1bn rayzebio buy BioProcess Insider Mon, 26 Feb 2024 08:00:00 GMT
• monashee investment management llc acquires shares of 27,500 rayzebio, inc. (nasdaq:ryzb) MarketBeat Sun, 25 Feb 2024 21:08:00 GMT
• bristol myers announces expiration of tender offer for rayzebio - tipranks.com TipRanks Sat, 24 Feb 2024 12:13:37 GMT
• Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer Business Wire Fri, 23 Feb 2024 08:00:00 GMT
• bristol myers squibb nears rayzebio acquisition completion by investing.com Investing.com Australia Fri, 23 Feb 2024 08:00:00 GMT
• bristol myers wraps rayzebio tender offer with 86% of shares MarketWatch Fri, 23 Feb 2024 08:00:00 GMT
• bristol myers announces expiration of tender offer for rayzebio - tipranks.com TipRanks Fri, 23 Feb 2024 08:00:00 GMT
• rayzebio (nasdaq:ryzb) sets new 52-week high at $62.42 Defense World Fri, 16 Feb 2024 10:59:10 GMT
• sofinnova’s maha katabi on recent m&a and ipo success and how deal flow has ‘never been any better’ Endpoints News Fri, 16 Feb 2024 08:00:00 GMT
• maven securities ltd makes new investment in rayzebio, inc. (nasdaq:ryzb) MarketBeat Fri, 16 Feb 2024 00:34:11 GMT
• maven securities ltd makes new investment in rayzebio, inc. (nasdaq:ryzb) MarketBeat Thu, 15 Feb 2024 15:50:07 GMT
• rayzebio (nasdaq:ryzb) reaches new 12-month high at $62.42 MarketBeat Thu, 15 Feb 2024 00:22:48 GMT
• rayzebio (nasdaq:ryzb) reaches new 12-month high at $62.42 MarketBeat Wed, 14 Feb 2024 16:08:20 GMT
• bristol myers squibb to issue corporate bonds for karuna and rayzebio acquisitions BNN Breaking Wed, 14 Feb 2024 14:25:33 GMT
• Bayer cowboys up with PanTera, a supplier of starting material for next-gen radiopharmaceuticals Fierce Pharma Wed, 14 Feb 2024 08:00:00 GMT
• bristol myers is tapping us high-grade bond market to fund m&a Bloomberg Wed, 14 Feb 2024 08:00:00 GMT
• bristol myers sees over $85 billion of demand for m&a bond sale Bloomberg Wed, 14 Feb 2024 08:00:00 GMT
• bayer ups its ante in radiopharma, signing on with pantera FiercePharma Wed, 14 Feb 2024 08:00:00 GMT
• bristol myers squibb to acquire rayzebio for $4.1 billion by investing.com Investing.com Nigeria Tue, 13 Feb 2024 09:28:14 GMT
• halper sadeh llc investigates potential securities law violations in inhibrx and rayzebio sales BNN Breaking Tue, 13 Feb 2024 02:04:04 GMT
• shareholder update: halper sadeh llc investigates door, zfox, ryzb InvestorsObserver Mon, 12 Feb 2024 17:15:00 GMT
• Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period Business Wire Mon, 12 Feb 2024 08:00:00 GMT
• brodsky & smith shareholder update: notifying investors of GlobeNewswire Mon, 12 Feb 2024 08:00:00 GMT
• bristol myers announces expiration of hsr waiting period to acquire rayzebio TipRanks Mon, 12 Feb 2024 08:00:00 GMT
• bristol myers squibb to acquire rayzebio for $4.1 billion Investing.com Mon, 12 Feb 2024 08:00:00 GMT
• rayzebio stock ticks higher after hsr waiting period for bristol myers deal expires Seeking Alpha Mon, 12 Feb 2024 08:00:00 GMT
• bms makes second big buy of december, pays $4.1bn for rayzebio Scrip Fri, 09 Feb 2024 13:42:29 GMT
• RayzeBio co-founder, industry veterans launch new biotech VC with $310 million statnews.com Wed, 07 Feb 2024 08:00:00 GMT
• vivo capital llc acquires shares of 633576 rayzebio, inc. (nasdaq:ryzb) MarketBeat Tue, 06 Feb 2024 18:41:48 GMT
• investigation alert: halper sadeh llc investigates dske, ryzb, grph, rovr GlobeNewswire Fri, 02 Feb 2024 08:00:00 GMT
• shareholder notice: halper sadeh llc investigates ryzb, fgh, axnx, amam Marketscreener.com Tue, 30 Jan 2024 04:03:03 GMT
• 2024-01-26 | nyse:bmy | press release | bristol-myers squibb co Stockhouse Publishing Sat, 27 Jan 2024 03:18:59 GMT
• rayzebio investor alert by the former attorney general of louisiana: kahn swick & foti, llc ... PR Newswire Sat, 27 Jan 2024 03:03:00 GMT
• rayzebio investor alert by the former attorney general of louisiana: kahn swick & foti, llc ... PR Newswire Fri, 26 Jan 2024 08:00:00 GMT
• 2024-01-26 | rayzebio investor alert by the former attorney general of louisiana: kahn swick ... Stockhouse Publishing Fri, 26 Jan 2024 08:00:00 GMT
• RayzeBio drew other pharma interest before Bristol Myers deal BioPharma Dive Thu, 25 Jan 2024 08:00:00 GMT
• BMS won out against other pharmas in bid for RayzeBio, just days after competing for Karuna Fierce Biotech Thu, 25 Jan 2024 08:00:00 GMT
• bristol myers squibb, rayzebio expect to file us antitrust paperwork on jan. 25 MLex Thu, 25 Jan 2024 08:00:00 GMT
• shareholder notice: halper sadeh llc investigates krtx, ryzb, via Marketscreener.com Tue, 23 Jan 2024 19:46:07 GMT
• versant venture management llc acquires new stake in rayzebio, inc. (nasdaq:ryzb) MarketBeat Tue, 23 Jan 2024 00:26:25 GMT
• 72610 shares in rayzebio, inc. (nasdaq:ryzb) bought by td asset management inc MarketBeat Sun, 21 Jan 2024 10:06:27 GMT
• platinum investment management ltd. buys new position in rayzebio, inc. (nasdaq:ryzb) MarketBeat Sun, 21 Jan 2024 08:00:00 GMT
• shareholder alert: the m&a class action firm continues investigating the merger – ryzb, thrx, amam, cstr EIN News Sat, 20 Jan 2024 01:28:39 GMT
• shareholder rights investigation: halper sadeh llc investigates brbs, ryzb, via, cpe GlobeNewswire Wed, 17 Jan 2024 05:01:27 GMT
• 2024-01-16 | ndaq:cstr | press release | capstar financial holdings inc Stockhouse Publishing Tue, 16 Jan 2024 23:33:41 GMT
• shareholder rights investigation: halper sadeh llc investigates ryzb, cpe, via, grcl GlobeNewswire Sat, 13 Jan 2024 13:51:51 GMT
• stockholder alert: the m&a class action firm continues investigating the merger - ryzb, fgh, amam, cstr Kilgore News Herald Sat, 13 Jan 2024 01:30:00 GMT
• Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players... PR Newswire Thu, 11 Jan 2024 08:00:00 GMT
• shareholder rights investigation: halper sadeh llc investigates ryzb, via, cpe, fgh GlobeNewswire Wed, 10 Jan 2024 02:05:00 GMT
• shareholder alert: rigrodsky law, p.a. is investigating rayzebio, inc. buyout Barron's Tue, 09 Jan 2024 08:00:00 GMT
• jpm 2024: biotech companies mapping out their future, and a new round of m&a spree begins geneonline Tue, 09 Jan 2024 08:00:00 GMT
• 2024-01-08 | nyse:cpe | press release | callon petroleum co Stockhouse Publishing Mon, 08 Jan 2024 22:13:12 GMT
• Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company' CNBC Mon, 08 Jan 2024 08:00:00 GMT
• JPM24: Bristol Myers Squibb CEO Boerner emphasizes organic pipeline over recent M&A deals Fierce Pharma Mon, 08 Jan 2024 08:00:00 GMT
• at jpm, ceo boerner says bms is set to grow by end of the decade FiercePharma Mon, 08 Jan 2024 08:00:00 GMT
• the therapeutic areas that stood out in biospace's nextgen class of 2024 BioSpace Mon, 08 Jan 2024 08:00:00 GMT
• kuehn law encourages krtx, dske, ryzb, and grcl investors to contact law firm Marketscreener.com Mon, 08 Jan 2024 08:00:00 GMT
• bms makes second big buy of december, pays $4.1bn for rayzebio Scrip Thu, 04 Jan 2024 23:36:03 GMT
• bristol myers squibb acquires rayzebio in $4.1bn deal — financier worldwide Financier Worldwide Thu, 04 Jan 2024 12:55:40 GMT
• shareholder investigation : halper sadeh llc investigates ryzb, krtx, grcl Marketscreener.com Thu, 04 Jan 2024 08:01:03 GMT
• advancell appoints anna karmann, md, phd as chief medical officer Business Wire Thu, 04 Jan 2024 08:00:00 GMT
RayzeBio Inc(NASDAQ:RYZB) 
RayzeBio is a clinical-stage radiopharmaceutical therapeutics (“RPT”) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs.
Website: https://rayzebio.com/
Founded: 2020
CEO: Dr. Kenneth Song
Sector: Healthcare
Industry: Biotechnology